Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
deals
fda
3
×
life sciences
national blog main
national top stories
aegle therapeutics
aligos therapeutics
alzheimer's disease
amag pharmaceuticals
aquestive therapeutics
arch venture partners
arimoclomol
astrazeneca
autoimmune diseases
aztherapies
bayer
bial
biomolecular condensates
boulder/denver blog main
boulder/denver top stories
c4 therapeutics
cancer immunotherapy
carmot therapeutics
cell therapy
covid-19. albert bourla
covis group
cstone pharmaceuticals
curevac
detroit blog main
detroit top stories
dewpoint therapeutics
diazepam
duchenne muscular dystrophy
europe blog main
europe top stories
fibrosis
filgotinib
What
caught
3
×
amid
bio
bombast
cancer
coronavirus
debate
develop
discussion
efforts
meso’s
miss
pandemic
pfizer’s
presidential
promise
response
roundup
tuesday’s
vaccine
viewers
causing
dicerna
disease
drug
eye
gene
hepatitis
intended
medicines
pay
pharma
pharmaceuticals
producing
protein
research
roche
stop
team
Language
unset
Current search:
caught
×
fda
×
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
